Infectious Diseases (except HIV/AIDS)
-
Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine
This article has 14 authors:Reviewed by ScreenIT
-
Tracing the trajectories of SARS-CoV-2 variants of concern between December 2020 and September 2021 in the Canary Islands (Spain)
This article has 13 authors:Reviewed by ScreenIT
-
Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims Databases
This article has 8 authors:Reviewed by ScreenIT
-
Study on the usefulness of Direct Saliva sample Collection (DiSC) by polyester swab
This article has 7 authors:Reviewed by ScreenIT
-
Presence of Symptoms 6 Weeks After COVID-19 Among Vaccinated and Unvaccinated U.S. Healthcare Personnel
This article has 14 authors:Reviewed by ScreenIT
-
CoviVac vaccination induces production of neutralizing antibodies against Delta and Omicron variants of SARS-CoV-2
This article has 15 authors:Reviewed by ScreenIT
-
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
This article has 14 authors:Reviewed by ScreenIT
-
Quantifying antibody dynamics of severe and non-severe patients with COVID-19
This article has 5 authors:Reviewed by ScreenIT
-
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
This article has 8 authors:Reviewed by ScreenIT
-
SARS-CoV-2 RNA Wastewater Settled Solids Surveillance Frequency and Impact on Predicted COVID-19 Incidence Using a Distributed Lag Model
This article has 7 authors:Reviewed by ScreenIT